Capital Advisors Ltd’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$97K Buy
251
+1
+0.4% +$371 0.01% 399
2026
Q1
$73K Sell
250
-12
-5% -$3.94K 0.01% 437
2025
Q4
$92K Buy
262
+11
+4% +$3.72K 0.01% 383
2025
Q3
$81K Buy
251
+45
+22% +$14K 0.01% 400
2025
Q2
$80K Sell
206
-14
-6% -$5.63K 0.01% 389
2025
Q1
$96K Buy
220
+14
+7% +$5.62K 0.01% 345
2024
Q4
$76K Sell
206
-37
-15% -$15.5K 0.01% 384
2024
Q3
$126K Sell
243
-6
-2% -$3.21K 0.02% 316
2024
Q2
$135K Buy
249
+1
+0.4% +$529 0.02% 313
2024
Q1
$129K Buy
248
+20
+9% +$9.95K 0.02% 320
2023
Q4
$108K Buy
228
+4
+2% +$1.85K 0.02% 326
2023
Q3
$98K Buy
224
+13
+6% +$5.9K 0.02% 331
2023
Q2
$94K Buy
211
+200
+1,818% +$92.3K 0.01% 344
2023
Q1
$5K Sell
11
-195
-95% -$92.8K ﹤0.01% 674
2022
Q4
$1K Buy
206
+197
+2,189% +$100K ﹤0.01% 983
2022
Q3
$4K Buy
9
+2
+29% +$957 ﹤0.01% 670
2022
Q2
$3K Buy
7
+1
+17% +$495 ﹤0.01% 617
2022
Q1
$3K Buy
6
+4
+200% +$1.83K ﹤0.01% 609
2021
Q4
$1K Buy
+2
New +$841 ﹤0.01% 652

Other funds holding ELV

Capital Advisors Ltd's ELV Position: Q2 2026 in Review

Capital Advisors Ltd increased its Elevance Health (ELV) stake by 0.4% in Q2 2026, buying an estimated $371 and bringing the position to 251 shares worth $97K. The position accounts for 0.01% of the portfolio, ranked #399.

Capital Advisors Ltd first reported a position in ELV in Q4 2021 and has held it in 19 quarters since. The position peaked at $135K in Q2 2024. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Capital Advisors Ltd held 251 shares of Elevance Health worth $97K as of Q2 2026.
  • Capital Advisors Ltd bought 1 Elevance Health share in Q2 2026, an estimated $371.
  • Elevance Health made up 0.01% of Capital Advisors Ltd's portfolio in Q2 2026, its #399 holding.
  • Capital Advisors Ltd first reported a position in Elevance Health in Q4 2021 and has held it in 19 quarters since.
  • Capital Advisors Ltd's Elevance Health position peaked at $135K in Q2 2024.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Capital Advisors Ltd's 13F filing for Q2 2026, filed 16 Jul 2026.